GW&K Investment Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9M | Buy |
2,890,130
+26,143
| +0.9% | +$487K | 0.48% | 67 |
|
|
2025
Q1 | $54.9M | Buy |
2,863,987
+740,499
| +35% | +$14.2M | 0.51% | 62 |
|
|
2024
Q4 | $76.5M | Buy |
2,123,488
+323,674
| +18% | +$11.7M | 0.65% | 37 |
|
|
2024
Q3 | $76.3M | Buy |
1,799,814
+456,703
| +34% | +$19.4M | 0.65% | 33 |
|
|
2024
Q2 | $54.1M | Buy |
1,343,111
+37,202
| +3% | +$1.5M | 0.49% | 72 |
|
|
2024
Q1 | $46.2M | Buy |
1,305,909
+79,151
| +6% | +$2.8M | 0.41% | 96 |
|
|
2023
Q4 | $36.3M | Buy |
+1,226,758
| New | +$36.3M | 0.34% | 125 |
|